Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—Current Considerations for Clinical Practice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular Comorbidities in Chronic Obstructive Pulmonary Disease (COPD)—Current Considerations for Clinical Practice
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 8, Issue 1, Pages 69
Publisher
MDPI AG
Online
2019-01-11
DOI
10.3390/jcm8010069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple coupled resonances in the human vascular tree: refining the Westerhof model of the arterial system
- (2018) Gerhard Schumacher et al. JOURNAL OF APPLIED PHYSIOLOGY
- Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial
- (2018) Jens M Hohlfeld et al. Lancet Respiratory Medicine
- Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial
- (2018) David B Price et al. Lancet Respiratory Medicine
- Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease
- (2018) Philip D. Adamson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
- (2017) Robert D Brook et al. HEART
- Expert consensus document: A 'diamond' approach to personalized treatment of angina
- (2017) Roberto Ferrari et al. Nature Reviews Cardiology
- Inhaled bronchodilators and acute myocardial infarction: a nested case-control study
- (2017) Chang-Hoon Lee et al. Scientific Reports
- The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis
- (2017) Paola Rogliani et al. International Journal of Chronic Obstructive Pulmonary Disease
- Chronic obstructive pulmonary disease comorbidities
- (2016) Jeanette P. Brown et al. CURRENT OPINION IN PULMONARY MEDICINE
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
- (2016) Brian Lipworth et al. HEART
- Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial
- (2016) Michael T. Durheim et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Accuracy of commercial devices and methods for noninvasive estimation of aortic systolic blood pressure a systematic review and meta-analysis of invasive validation studies
- (2016) Theodore G. Papaioannou et al. JOURNAL OF HYPERTENSION
- Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
- (2016) Jørgen Vestbo et al. LANCET
- Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
- (2016) Jadwiga A. Wedzicha et al. NEW ENGLAND JOURNAL OF MEDICINE
- The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline
- (2016) Annika Karch et al. RESPIRATORY MEDICINE
- Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease
- (2016) Gianna Camiciottoli et al. International Journal of Chronic Obstructive Pulmonary Disease
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- (2015) EUROPACE
- Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study
- (2015) Lies Lahousse et al. EUROPEAN HEART JOURNAL
- Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis
- (2015) Rita Pavasini et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial
- (2015) A. Neukamm et al. JOURNAL OF INTERNAL MEDICINE
- The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational research
- (2015) Chao Cao et al. Scientific Reports
- -Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
- (2015) P. Andell et al. Journal of the American Heart Association
- Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study
- (2015) Pere Almagro et al. International Journal of Chronic Obstructive Pulmonary Disease
- The stats are in: an update on statin use in COPD
- (2015) Debra Reid et al. International Journal of Chronic Obstructive Pulmonary Disease
- Dyspnea and Reversibility Profile of P2Y12 Antagonists: Systematic Review of New Antiplatelet Drugs
- (2014) Daniel Caldeira et al. American Journal of Cardiovascular Drugs
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- Plasma activity of B-type natriuretic peptide in patients with biventricular heart failure versus those with right heart failure due to chronic obstructive pulmonary disease
- (2014) Nikolaos Flessas et al. Journal of Cardiovascular Medicine
- Inhaled beta-2-agonists/muscarinic antagonists and acute myocardial infarction in COPD patients
- (2014) Marietta Rottenkolber et al. RESPIRATORY MEDICINE
- M138 Do Standard Cardiovascular Risk Scores Identify Risk In Patients With Copd?
- (2014) M. John et al. THORAX
- Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality
- (2014) Michelle C Williams et al. THORAX
- Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD
- (2013) William B. White et al. CHEST
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- 2013 ESC guidelines on the management of stable coronary artery disease
- (2013) EUROPEAN HEART JOURNAL
- Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services
- (2013) N. M. Hawkins et al. EUROPEAN HEART JOURNAL
- Airway obstruction in systolic heart failure – COPD or congestion?
- (2013) Susanne Brenner et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pulmonary Hypertension in Chronic Lung Diseases
- (2013) Werner Seeger et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease
- (2013) Andrea Gershon et al. JAMA Internal Medicine
- Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index
- (2012) Charlotte H. Manisty et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pulmonary Hypertension Due to Left Heart Disease
- (2012) Marco Guazzi et al. CIRCULATION
- Renin–angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease
- (2012) Dinesh Shrikrishna et al. CLINICAL SCIENCE
- Effect of Statins on Total Cholesterol Concentrations, Cardiovascular Morbidity, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
- (2012) Xia Sheng et al. CLINICAL THERAPEUTICS
- Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey
- (2012) R. Pisters et al. EUROPACE
- Measurement accuracy of non-invasively obtained central blood pressure by applanation tonometry: A systematic review and meta-analysis
- (2012) Hao-Min Cheng et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Impact of Chronic Obstructive Pulmonary Disease on Procedural Outcomes and Quality of Life in Patients with Atrial Fibrillation Undergoing Catheter Ablation
- (2012) JUN GU et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Statins, systemic inflammation and risk of death in COPD: The Rotterdam study
- (2012) Lies Lahousse et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case–control study (CONSISTE study)
- (2012) Pilar Lucas et al. International Journal of Chronic Obstructive Pulmonary Disease
- Increased Adverse Events After Percutaneous Coronary Intervention in Patients With COPD
- (2011) Jonathan R. Enriquez et al. CHEST
- Catheter Ablation of Atrial Fibrillation in Patients With Chronic Lung Disease
- (2011) Seung-Young Roh et al. Circulation-Arrhythmia and Electrophysiology
- Unrecognised ventricular dysfunction in COPD
- (2011) A. Macchia et al. EUROPEAN RESPIRATORY JOURNAL
- Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial
- (2011) Mitja Lainscak et al. RESPIRATORY MEDICINE
- Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice
- (2011) PIERA BOSCHETTO et al. RESPIROLOGY
- β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing
- (2010) Jeffrey J. Goldberger et al. AMERICAN HEART JOURNAL
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
- (2010) Frans H. Rutten ARCHIVES OF INTERNAL MEDICINE
- Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol Combination
- (2010) Pierre Boutouyrie et al. HYPERTENSION
- The cardiopulmonary continuum systemic inflammation as ‘common soil’ of heart and lung disease
- (2010) Christian Ukena et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Effect of Antihypertensive Drugs on Central Blood Pressure Beyond Peripheral Blood Pressure. Part II: Evidence for Specific Class-Effects of Antihypertensive Drugs on Pressure Amplification
- (2009) Athanase Protogerou et al. CURRENT PHARMACEUTICAL DESIGN
- Do Inhaled Anticholinergics Increase or Decrease the Risk of Major Cardiovascular Events?
- (2009) Shelley R. Salpeter DRUGS
- Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?
- (2009) Kang-Ling Wang et al. JOURNAL OF HYPERTENSION
- Usefulness of C-Reactive Protein and Interleukin-6 as Predictors of Outcomes in Patients With Chronic Obstructive Pulmonary Disease Receiving Pravastatin
- (2008) Tsung-Ming Lee et al. AMERICAN JOURNAL OF CARDIOLOGY
- Inhibition of the renin-angiotensin system in severe COPD
- (2008) L. Mascitelli et al. EUROPEAN RESPIRATORY JOURNAL
- Central But Not Brachial Blood Pressure Predicts Cardiovascular Events in an Unselected Geriatric Population
- (2008) Riccardo Pini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Underdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation
- (2008) Pål H. Brekke et al. RESPIRATORY MEDICINE
- Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome of Patients Hospitalized for Heart Failure
- (2007) Dan Rusinaru et al. AMERICAN JOURNAL OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started